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Abstract: Manifestation of Hodgkin’s malignant disease in dogs has a low incidence in Romania. 
Detailed cyto-morphological analysis of canine Hodgkin’s malignant granuloma, is particularly 
important, as it can avoid some diagnosis errors, in a significant number of anatomical and clinical 
forms of cancer disease with giant cells. It shows some representative images and details of 
comparative diagnosis and specific comment. There can be noticed that mono or polynuclear giant 
cells in dogs are associated with malignant cells in different locations, while in Hodgkin’s disease they 
are placed exclusively in malignant granuloma. Diagnostic errors that can occur are discussed, 
according to the presented images. 
 




Manifestation of Hodgkin’s malignant disease in dogs has a low incidence in 
Romania. Detailed cyto-morphological analysis of canine Hodgkin’s malignant granuloma, is 
particularly important, as it can avoid some diagnosis errors, in a significant number of 
anatomical and clinical forms of cancer disease with giant cells. It shows some representative 
images and details of comparative diagnosis and specific comment. There can be noticed that 
mono or polynuclear giant cells in dogs are associated with malignant cells in different 
locations, while in Hodgkin’s disease they are placed exclusively in malignant granuloma. 
Diagnostic errors that can occur are discussed, according to the presented images. 
 
MATERIALS AND METHOD 
 
In the last five years, in the Medical Clinic of the Faculty of Veterinary Medicine – 
Bucharest a number of 6 cases of Hodgkin's malignant lymphoma in dogs were diagnosed. 
Cytomorphological diagnosis was accomplished either after surgical ablation of the spleen, as 
a result of ultrasound examination that showed tumoral splenomegalia, or after fine needle 
puncture of external adenopathies, as revealed by the anatomoclinic examination. 
Whatever the tissue source (spleen, lymph node), cytomorphological examinations were 
performed by smearing on slides (smears or impression smears), which were panoptically 
stained (MGG). 
 
RESULTS AND DISCUSSION 
 
Several evolutive forms of Hodgkin malignant lymphoma have been diagnosed following 
cytomorphological investigations, represented by: 
- Hodgkin’s malignant lymphoma granulomatous stage. 
- This stage has some cytological coordonates supporting positive and differential 
diagnosis as well. 
- The general appearance is of granulomatous inflammation, consisting of a cellular mix 
of adult B and T cells, plasmocytes, neutrophil granulocytes, eosinophil granulocytes 
and macrofages together with frequent fibrocytes and fibroblasts. Specific cells of 
Hodgkin’s malignant lymphoma, namely mononuclear Hodgkin giant cells and 
polynuclear  Stemberg-Paltauff-Reed cells, can be identified within this cell mix. 
These cells that characterize and always accompany Hodgkin’s malignant 
limfoproliferation are always originary monocyto-macrophagic, over 30µ sized. The 
single nucleus is monstrous and occupies much of the cell surface. The nuclear 
chromatin shows a structure of anastomosed bands generating a pseudoreticular 
appearance, highlighting 2-3 giant nucleoli. The cytoplasm is basophilic and non-
granulated. Mitotic nuclei are not rare. These are giant Hodgkin cells. Stemberg cells 
are giant polynucleated and very large cells, over 40-50 µ sized. These cells have a 
chain of monstrous nuclei (4-6), with relative condensed chromatin, highlighting 1-2 
large intense basophilic nuclei, with large non-granulated slight basophilic cytoplasm. 
For this evolutive form it is necessary to perform a careful but easy differential 
diagnosis from a lymphonodal giant-cell granulomatous inflammation or/and splenic. 
The diagnosis of Hodgkin’s malignant lymphoma is supported in return whenever 
atypical monstrous malignant cells are identified within the granulomatous cell 
proliferation mass. 
Lymphonodal and / or splenic granulomatous inflammation can be in their turn foreign 
body or highly specific infectious inflammations. 
- Another evolutive form of diagnosed Hodgkin’s malignant lymphoma is represented 
by lymphocytic depletion. It is characterized by total quasilack of lymphocytic cells 
within the lymphonodal granulomatous cell structure and/or splenic on the one hand, 
and on the other hand a considerable increase of Hodgkin and Stemberg giant cells can 
be highlighted. 
- The last identified evolutive form of Hodgkin’s malignant lymphoma is represented by 
Hodgkin’s sarcoma. It consists exclusively of intensely proliferated  Hodgkin and 
Stemberg giant cells that replace the traditional aspects of granulomatous invasion. 
For both evolutive forms of Hodgkin’s lymphoma it is necessary to accomplish a 
careful differential diagnosis from: 
- Giant cell fibrosarcoma; 
- Osteoclastic osteosarcoma; 
- Rhabdomyosarcoma; 
- Histiocytic malignant lymphoma, 
A therapy consisting of a combination of spleen surgical excision followed by 
prolonged and sustained cures of chemotherapy is envisaged by our team, for 
histiocytic malignant lymphoma. This surgical therapy is not adequate for other forms 




1 – Canine Hodgkin’s malignant lymphoma shows a low frequency within the 
evolutive forms of malignant lymphomas. 
2 – It is important to recognize the morphopathology of this type of cancer, as it can 
be often misled for lymphonodal or splenic inflammatory status. 
3 – Positive and differential diagnosis of Hodgkin’s malignant lymphoma is essential 
for the therapeutic act in sick animal. 
4 – In the overall picture of malignant lymphoma terminology frequently used, it is 
essential to make the difference between Hodgkin’s/non-Hodgkin’s lymphoma, as the therapy 
is extremely different. 
5 – While splenectomy is the major choice in Hodgkin’s malignant lymphoma, in non-
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